Status:
COMPLETED
Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Peripheral Vascular Diseases
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
PHASE3
Brief Summary
The Mirror Study is a randomized, double-blinded mono-centre trial the access the periinterventinal and postinterventional administration of clopidogrel in patients with peripheral vascular disease.
Detailed Description
Clopidogrel is approved for secondary prevention of atherosclerosis in patients with peripheral vascular disease. Currently there are no data about the amount of platelet activation during peripheral ...
Eligibility Criteria
Inclusion
- Peripheral arterial disease which requires intervention
Exclusion
- Patient already on coumadin or clopidogrel
- Acute onset of PVD symptoms
- Patient requiring an operation
- Contraindication to aspirin and clopidogrel
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00163267
Start Date
September 1 2005
End Date
April 1 2011
Last Update
August 9 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Tuebingen
Tübingen, Germany, 72076